/ Modified jun 12, 2020 2:36 p.m.

Episode 236: Tracking treatment candidates for COVID-19

Can research lead to a fast track development for an anti-COVID-19 drug?

AZSCI 236 Tracking Treament UA Pharmacology researcher Jun Wang
Jun Wang

The Research Corporation for Science Advancement
Arizona Science

Tracking treatment candidates for COVID-19

This episode is supported by the The Research Corporation for Science Advancement.
Episode 236: University of Arizona Pharmacology researcher Jun Wang

A team at the University of Arizona investigating influenza found that some of the molecular compounds they were looking at can also stop the coronavirus. Pharmacologist Jun Wang thinks the research could lead to a fast track development for an anti-COVID-19 drug.

Jun Wang spoke with Leslie Tolbert, Ph. D professor emerita in Neuroscience at the University of Arizona.

Arizona Science
Catch Arizona Science each Friday during Science Friday on NPR 89.1. You can subscribe to our podcast on iTunes. See more from Arizona Science.
By posting comments, you agree to our
AZPM encourages comments, but comments that contain profanity, unrelated information, threats, libel, defamatory statements, obscenities, pornography or that violate the law are not allowed. Comments that promote commercial products or services are not allowed. Comments in violation of this policy will be removed. Continued posting of comments that violate this policy will result in the commenter being banned from the site.

By submitting your comments, you hereby give AZPM the right to post your comments and potentially use them in any other form of media operated by this institution.
AZPM is a service of the University of Arizona and our broadcast stations are licensed to the Arizona Board of Regents who hold the trademarks for Arizona Public Media and AZPM. We respectfully acknowledge the University of Arizona is on the land and territories of Indigenous peoples.
The University of Arizona